The role of GSTM1 and GSTT1 deletion variants and alcohol consumption profile in the development of alcoholic liver cirrhosis
Open Access
- 1 January 2026
- journal article
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 154 (3-4) , 164-170
Abstract
Introduction/Objective. Alcoholic liver cirrhosis (ALC) is the primary cause of alcohol abuse-related mortality, resulting from alcohol-induced oxidative stress. Glutathione S-transferases (GSTM1, GSTT1) are enzymes essential for detoxification, and their deficiency may contribute to the onset of chronic inflammation and disease progression. This study sought to investigate the relationship between GSTM1 and GSTT1 deletions and ALC, as well as alcohol consumption patterns in cirrhosis development. Methods. The analysis included 114 ALC patients and 262 controls, with GSTM1 and GSTT1 deletions assessed via multiplex PCR. Results. Findings indicated that individuals with the GSTM1 null genotype had a three-fold increased risk of developing ALC (95% CI, 1.87–4.81; p < 0.0001), whereas GSTT1 null genotypes showed no significant impact. Individuals with both GSTM1 null and GSTT1 null genotypes exhibited an 11-fold heightened risk of ALC (OR = 11.21, 95% CI = 3.30–38.14, p < 0.001). Furthermore, patients who commenced alcohol consumption at 22.5 years or older developed cirrhosis more rapidly than their younger counterparts (p < 0.001). Conclusion. GSTM1 null and combined GSTM1/GSTT1 null genotypes constitute significant risk factors for ALC, with patients who started drinking at an older age experiencing accelerated disease progression irrespective of alcohol intake levels.Keywords
Funding Information
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (451-03-66/2024-03/200042)
This publication has 27 references indexed in Scilit:
- Glutathione S-transferase Mu 3 Mitigates Alcohol-induced Hepatic Lipid Dysregulation via PYGM SuppressionBiochemical Pharmacology, 2026
- Glutathione S-transferase: A versatile and dynamic enzymeBiochemical and Biophysical Research Communications, 2024
- Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammationJournal of Hepatology, 2024
- Old age as a risk factor for liver diseases: Modern therapeutic approachesExperimental Gerontology, 2023
- Diagnosis and Management of Cirrhosis and Its ComplicationsJAMA, 2023
- Global burden of liver disease: 2023 updateJournal of Hepatology, 2023
- Effects of genetic risk for alcohol dependence and onset of regular drinking on the progression to alcohol dependence: A polygenic risk score approachDrug and Alcohol Dependence, 2021
- EASL Clinical Practice Guidelines: Management of alcohol-related liver diseaseJournal of Hepatology, 2018
- Polymorphism in glutathione-S-transferases: A risk factor in alcoholic liver cirrhosisDrug and Alcohol Dependence, 2009
- GSTP1, GSTM1, and GSTT1 genetic polymorphisms in patients with cryptogenic liver cirrhosisJournal of Gastrointestinal Surgery, 2004